EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A National User-satisfaction Survey, UK

Helen Couch iD, Andrew Pearson, Neha Malhotra iD, Michael Ferguson, George Couch iD, Clare Gilbert iD, Kate Morgan, Sarah Mann, Kelly Cassidy, Sarah Worthington, Elaine O'Shea, Maria SalomonEstebanez und 4 weitere

The Journal of Clinical Endocrinology & Metabolism · 18.12.2025 · 111 (1) · 139-148

DOI: 10.1210/clinem/dgaf313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 26.05.2025. Verfasst von Helen Couch und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK. Hauptthemen laut MEDLINE: Blood Glucose Self-Monitoring, Blood Glucose, Congenital Hyperinsulinism, Patient Satisfaction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Congenital hyperinsulinism (CHI) causes severe and recurrent hypoglycemia with a 33% to 50% risk of neurodisability necessitating rigorous glucose monitoring. Continuous glucose monitoring (CGM) is now widely used in CHI with limited data on user-reported benefits. There are no validated instruments available to assess the impact of CGM use on quality of life (QOL) in CHI.

Objective

To evaluate CGM user satisfaction of patients with CHI and their carers.

Design

Modified CGM-satisfaction (CGM-SAT) and glucose monitoring surveys (GMS) were distributed electronically to CHI families using CGM.

Setting

CHI highly specialized services, UK, May to August 2023. Patients or Other Participants Parents (n = 86) and teachers (n = 15) of patients with CHI using CGM (0-18 years old) and patients themselves if ≥7 years old (n = 20). Main Outcome Measures User-reported ease of CGM handling, influence of CGM on CHI management and QOL, and desire for continued use of CGM.

Results

Most respondents reacted positively to statements regarding: CGM device handling (58% agreed or strongly agreed), influence on CHI management (70%), QOL (75%), and continued use (86%). Satisfaction with CGM was positively correlated with duration of use (r = 0.40, P < 0.001). Eighty-six percent of users reported checking the CGM 1 to 5 times per hour. Users reported perceived improvements in safety, hypoglycemia detection, freedom, and independence, despite concerns with accuracy and device range.

Conclusion

Patients with CHI and their carers reported that they feel safer and perceive benefits from CGM in all aspects of living with CHI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Glucose Self-MonitoringBlood GlucoseCongenital HyperinsulinismPatient SatisfactionHumansFemaleUnited KingdomMaleInfantQuality of LifeAdolescentChild, PreschoolChildInfant, NewbornSurveys and QuestionnairesHypoglycemiaAdultPrognosisCaregiversContinuous Glucose Monitoring

Stichwörter der Autor:innen

CGMCHIcongenital hyperinsulinismcontinuous glucose monitoringexperienceshypoglycemiasatisfaction

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Paediatrics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
  • Quality and Safety Team, Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK.
  • Department of Paediatrics, Basildon University Hospital, Essex, SS16 5NL, UK.
  • Your Path Solutions, Toronto, ON, M6S2Y1, Canada.
  • Department of Anaesthetics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
  • Department of Oncology, Cancer Research UK - Cambridge Institute, Cambridge, CB2 0RE, UK.

ORCID-Profile: Helen Couch, Neha Malhotra, George Couch, Clare Gilbert, Chris Worth, Indraneel Banerjee, Antonia Dastamani

Zitieren

APA

Couch, H., Pearson, A., Malhotra, N., Ferguson, M., Couch, G., Gilbert, C., Morgan, K., Mann, S., Cassidy, K., Worthington, S., O'Shea, E., SalomonEstebanez, M., Worth, C., Senniappan, S., Banerjee, I., & Dastamani, A. (2025). Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A National User-satisfaction Survey, UK. The Journal of Clinical Endocrinology & Metabolism, 111(1), 139-148. https://doi.org/10.1210/clinem/dgaf313

Vancouver

Couch H, Pearson A, Malhotra N, Ferguson M, Couch G, Gilbert C, et al. Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A National User-satisfaction Survey, UK. The Journal of Clinical Endocrinology & Metabolism. 2025;111(1):139-148. doi:10.1210/clinem/dgaf313

BibTeX
@article{Couch2025,
  author = {Couch, Helen and Pearson, Andrew and Malhotra, Neha and Ferguson, Michael and Couch, George and Gilbert, Clare and Morgan, Kate and Mann, Sarah and Cassidy, Kelly and Worthington, Sarah and O'Shea, Elaine and SalomonEstebanez, Maria and Worth, Chris and Senniappan, Senthil and Banerjee, Indraneel and Dastamani, Antonia},
  title = {Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A National User-satisfaction Survey, UK},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {111},
  number = {1},
  pages = {139--148},
  doi = {10.1210/clinem/dgaf313}
}
Kostenlos starten →